Araştırma Makalesi

Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center

Cilt: 16 Sayı: 1 25 Mart 2025
PDF İndir
TR EN

Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center

Öz

Aim: For the majority of left main coronary artery (LM) bifurcation lesions treated with percutaneous coronary intervention, one-stent crossover technique and provisional approach to the side branch is recommended, which is simpler compared to complex two-stent techniques. In this study, we aimed to reveal the clinical outcomes of one-stent crossover approach for LM bifurcation. Material and Methods: Patients who underwent one-stent crossover technique for unprotected LM bifurcation lesion between May 2020 and November 2023 in our center were included in this retrospective observational study. Clinical and procedural characteristics of the patients were recorded. All patients or their relatives were called to inquire about clinical outcomes. The primary endpoint was determined as target lesion failure (TLF), which was defined as clinically driven target lesion revascularization (TLR), target lesion-related myocardial infarction (TL-MI), or sudden cardiac death (SCD). Results: A total of 86 patients were included in the study. Crossover stenting was performed from the LM to the left anterior descending artery (LAD) in 76 patients and from the LM to the left circumflex artery (LCX) in 8 patients. The median follow-up time was 22 (3-54) months. Clinically driven TLR occurred in 2 patients, TL-MI in 1 patient, and SCD in 1 patient. TLF criteria were met in only 3 patients. Of these patients, 2 had undergone LM-LAD and 1 had undergone LM-LCX crossover stenting. Conclusion: One-stent crossover approach for LM bifurcation lesions is associated with very good clinical outcomes.

Anahtar Kelimeler

Kaynakça

  1. Burzotta F, Lassen JF, Lefèvre T, et al. Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club. EuroIntervention 2021; 16: 1307-17.
  2. Cho S, Kim JS, Kang TS, et al. Long-Term Efficacy of Extended Dual Antiplatelet Therapy After Left Main Coronary Artery Bifurcation Stenting. Am J Cardiol 2020; 125: 320-7.
  3. Kim WJ, Kim YH, Park DW, et al. Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease. Catheter Cardiovasc Interv 2011; 77: 775-82.
  4. Zhang JJ, Ye F, Xu K, et al. Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial. Eur Heart J 2020; 41: 2523-36.
  5. Chen SL, Zhang JJ, Han Y, et al. Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial. J Am Coll Cardiol 2017; 70: 2605-17.
  6. Hildick-Smith D, Egred M, Banning A, et al. The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN). Eur Heart J 2021; 42: 3829-39.
  7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-421.
  8. Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013; 158: 825-30.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Kardiyoloji

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

25 Mart 2025

Gönderilme Tarihi

11 Aralık 2024

Kabul Tarihi

28 Şubat 2025

Yayımlandığı Sayı

Yıl 2025 Cilt: 16 Sayı: 1

Kaynak Göster

APA
Yıldırım, U., & Altınbaş, A. (2025). Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center. Turkish Journal of Clinics and Laboratory, 16(1), 106-112. https://doi.org/10.18663/tjcl.1599187
AMA
1.Yıldırım U, Altınbaş A. Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center. TJCL. 2025;16(1):106-112. doi:10.18663/tjcl.1599187
Chicago
Yıldırım, Ufuk, ve Alperen Altınbaş. 2025. “Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center”. Turkish Journal of Clinics and Laboratory 16 (1): 106-12. https://doi.org/10.18663/tjcl.1599187.
EndNote
Yıldırım U, Altınbaş A (01 Mart 2025) Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center. Turkish Journal of Clinics and Laboratory 16 1 106–112.
IEEE
[1]U. Yıldırım ve A. Altınbaş, “Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center”, TJCL, c. 16, sy 1, ss. 106–112, Mar. 2025, doi: 10.18663/tjcl.1599187.
ISNAD
Yıldırım, Ufuk - Altınbaş, Alperen. “Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center”. Turkish Journal of Clinics and Laboratory 16/1 (01 Mart 2025): 106-112. https://doi.org/10.18663/tjcl.1599187.
JAMA
1.Yıldırım U, Altınbaş A. Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center. TJCL. 2025;16:106–112.
MLA
Yıldırım, Ufuk, ve Alperen Altınbaş. “Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center”. Turkish Journal of Clinics and Laboratory, c. 16, sy 1, Mart 2025, ss. 106-12, doi:10.18663/tjcl.1599187.
Vancouver
1.Ufuk Yıldırım, Alperen Altınbaş. Clinical outcomes of one-stent crossover approach for left main bifurcation in a single center. TJCL. 01 Mart 2025;16(1):106-12. doi:10.18663/tjcl.1599187

e-ISSN: 2149-8296

Publication Model: Continuous Publication

Peer Review Model: Double-Blind Peer Review

Publication Language: Turkish and English

Access Model: Open Access

DOI Prefix: (Crossref DOI numaranız)

Publisher: DNT Ortadoğu Publishing Inc.

Journal Abbreviation: Turk J Clin Lab

Indexed in J-Gate

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.